Overview of the VHPB
>> Supports and grantsclick to go back to previous page  click to go forward to the next page  click to print this page

The executive VHPB secretariat benefits from being seated at the Center for the Evaluation of Vaccination (CEV) of the University of Antwerpen, where it has the infrastructure and administrative services of the University at its disposal. The CEV is designated as a WHO collaborating center for control and prevention of viral hepatitis in Europe.

VHPB is supported by unrestricted grants from the vaccine industry (GlaxoSmithKline Biologicals, Sanofi Pasteur MSD, Sanofi Pasteur and Merck), several universities in Europe and other institutions.

The VHPB has in the past also received support from the Global Alliance for Vaccines and Immunisation Fund and the Children's Vaccine Program at PATH for its activities in CEE and NIS.

For the VHPB and its advisers strict operational and scientific independence is essential.
VHPB advisers and invited experts get only travel and subsistence reimbursed according to the University Rules, no honorary or other forms of remuneration are provided.